Trustmark (TRMK) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Net income for Q3 2024 was $51.3 million ($0.84 EPS), up from $34.0 million ($0.56 EPS) in Q3 2023 and $40.5 million in Q2 2024, reflecting a 26.7% linked-quarter increase and 51% year-over-year growth.
Tangible book value per share rose to $26.88, up 6.5% sequentially and 32.9% year-over-year.
Profitability improved with a 282 bps efficiency ratio improvement and a 9.5% increase in net interest income, driven by securities portfolio restructuring.
Return on average tangible equity was 12.86% and return on average assets was 1.10%.
Board declared a $0.23 per share dividend, payable December 15, 2024.
Financial highlights
Net interest income (FTE) for Q3 2024 was $158.0 million, up $13.7 million (9.5%) linked-quarter and 11.6% year-over-year; net interest margin increased 31 bps to 3.69%.
Noninterest income from adjusted continuing operations was $37.6 million, down $0.7 million sequentially but up $0.6 million year-over-year.
Noninterest expense for Q3 2024 was $123.3 million, up $4.9 million sequentially due to salary increases and OREO reserve, but down 5.4% year-over-year.
Loans held for investment were $13.1 billion, relatively flat sequentially, up 1.2% from year-end and 2.3% year-over-year.
Deposits totaled $15.2 billion, down $222 million sequentially due to targeted runoff, but up $139 million year-over-year.
Outlook and guidance
Loans held for investment expected to grow low single digits for full-year 2024; deposits (excluding brokered) to remain stable.
Net interest income projected to increase mid-single digits in 2024, with full-year net interest margin around 3.50% and H2 2024 margin of 3.65%-3.70%.
Noninterest income from adjusted continuing operations expected to rise low to mid-single digits; noninterest expense to remain approximately unchanged for 2024.
Management expects continued focus on organic loan growth, market expansion, disciplined capital deployment, and technology investments.
Economic uncertainty, interest rate volatility, and regulatory changes are expected to impact near-term results.
Latest events from Trustmark
- Record earnings, dividend increase, and strong ESG initiatives mark a year of growth and engagement.TRMK
Proxy Filing16 Mar 2026 - Key votes include director elections, executive pay approval, and auditor ratification for 2026.TRMK
Proxy Filing16 Mar 2026 - Record earnings, robust governance, and strong ESG drive 2026 proxy voting recommendations.TRMK
Proxy Filing16 Mar 2026 - Record earnings, higher dividend, and strong capital ratios highlight robust 2025 performance.TRMK
Q4 20253 Feb 2026 - Q2 net income surged on FBBI sale, despite a $182.8M securities loss, with stronger capital.TRMK
Q2 20243 Feb 2026 - Q4 net income up 9.7%, capital and EPS rise on asset sales, with a strong 2025 outlook.TRMK
Q4 20249 Jan 2026 - Q1 2025 net income reached $53.6M, with strong loan growth and stable credit quality.TRMK
Q1 202525 Dec 2025 - 2024 featured strong financial gains, enhanced capital returns, and expanded ESG and governance initiatives.TRMK
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor, all board-backed.TRMK
Proxy Filing1 Dec 2025